None listed
Conditions
Interventions
Medical Device : 200ml or more of sterile saline is injected into a cooling saline bag, and after pre-cooling, patient anesthesia, and positioning, jelly is applied and inserted into the rectum while
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients with histopathologically diagnosed prostate cancer Clinical stage with T1-T3aN0M0 ECOG Performance status is 0-1 Patients planning to preserve bilateral neurobascular bundle (Tewari’s grade 1-2 OR Patel’s grade 3-5) Patients who can read and consent to informed consent
Exclusion criteria
Exclusion criteria: Patients who have received prior treatment for prostate cancer, such as radiation therapy, chemotherapy, or hormone therapy, before surgery or are planned after surgery Those who have had previous surgery or radiation therapy in the pelvic cavity Those with a previous diagnosis of urinary incontinence or neurogenic bladder Those with neurological problems such as central nervous system disease or peripheral neuropathy Those who are judged by the investigator to be inappropriate to participate in other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients using less than 1 pad at 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary incontinence recovery status over time, erection recovery status over time, inflammation-related values ??on the first day after surgery, and complications at 90 days after surgery | — |
Countries
Korea, Republic of
Contacts
Public ContactJae Hoon Chung
Samsung Medical Center
Outcome results
None listed